A case of tacrolimus nephrotoxicity appearing in a second renal transplantation patient

Clinical Transplantation

Volumn 15, Issue SUPPL. 5, 2001, Pages 30-34

  Oka, K ^a   Moriyama, T ^a   Imai, E ^a   Kyo, M ^a   Toki, K ^a   Tanaka, T ^a   Hori, M ^a   Kokado, Y ^a   Okuyama, A ^a   Takahara, S ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclosporin; Renal transplantation; Repeated graft biopsies; Tacrolimus nephrotoxicity

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; CYCLOSPORIN; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; CLINICAL OBSERVATION; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG USE; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; REOPERATION;

BIOPSY; CYCLOSPORINE; FIBROSIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS; TACROLIMUS;

EID: 0035658636     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2001.0150s5030.x     Document Type: Article

References (8)

1. Tacrolimus: An update of its pharmacology and clinical efficacy in the management of organ transplantation
2. Clinical and histological analysis of acute tacrolimus (TAC) nephrotoxicity in renal allografts
3. Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations
4. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: An interim report
5. FK506 Kidney Transplant Group. Tacrolimus (FK506) in kidney transplantation: Three-year survival results of US multicenter, randomised, comparative trial
6. Tacrolimus: A further update of its pharmacology and therapeutic use in the management of organ transplantation
7. Tacrolimus: A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation
8. Molecular mechanisms of immunosuppressive chemical agents recently introduced in clinical transplantation protocols